首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cancer Investigation

Cancer Investigation杂志,由Informa Healthcare出版,于1983年创刊,Bimonthly,出版语言English,ISSN:0735-7907,E-ISSN:1532-4192。

投稿咨询
Cancer Investigation
Cancer Investigation
Cancer Investigation
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.2
CiteScore
3.7
期刊收录
SCI、SCIE

Cancer Investigation(中文译名:《癌症调查》),ISSN:0735-7907,EISSN:1532-4192,是Informa Healthcare出版的国际性学术期刊,创刊于1983年,以Bimonthly形式稳定发行,2026年总发文量约87篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.2,2025年期刊CiteScore为3.7,2025年期刊自引率约4.5%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Cancer Investigation长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约8.5月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Japan、India、Italy、Iran、France等为核心发文国家与地区;COLUMBIA UNIVERSITYSTATE UNIVERSITY SYSTEM OF FLORIDA、FUDAN UNIVERSITY、JOHNS HOPKINS UNIVERSITY、UNIVERSITY OF LOUISVILLE、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、CHINESE ACADEMY OF SCIENCES等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 228 / 333

31.7

学科:ONCOLOGY SCIE Q3 249 / 333

25.38

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 243 / 328

26.1

学科:ONCOLOGY SCIE Q4 253 / 328

23.02


中国学者近期发文

1
Systematic Review and Single-Arm Meta-Analysis of Bevacizumab Combined with Chemotherapy or Immunotherapy for Oncological Outcomes in Advanced/Recurrent Ovarian Clear Cell Carcinom

Author:Gu, Yuling; Tang, Yunxian; Zheng, Cui; Wang, Yanhua

Journal: CANCER INVESTIGATION. 2026; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2026.2618578

2
Influence of Exercise Management for Frail Elderly Cancer Patients on Chemotherapy Tolerance and Complications: A Systematic Review and Meta-Analysi

Author:Ni, Yudan; Ye, Qing; Zhang, Ailing; Wang, Feng; Wu, Linke

Journal: CANCER INVESTIGATION. 2026; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2026.2617207

3
Prognostic Significance of Different Ki-67 Cutoff Values Defined Luminal B HER2-Negative Breast Cance

Author:Ye, Xin; Zhou, Xiaoyun; He, Qi; Wang, Jie; Yang, Li; Ji, Min; Wang, Zhiwei

Journal: CANCER INVESTIGATION. 2026; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2026.2617267

4
Advanced Machine Learning and Multiomics Reveal Tumor Dynamics and Therapeutic Opportunities in Glioblastoma Multiform

Author:Li, Jiaohong; Cheng, Jinnan; Wu, Yong; Lv, Zhiyu; Yuan, Ping

Journal: CANCER INVESTIGATION. 2026; Vol. 44, Issue 1, pp. 11-25. DOI: 10.1080/07357907.2025.2563204

5
Integrated Analysis of Slow Transit Constipation and Colorectal Cancer Reveals the Co-Pathogenic Targets and Their Potential Clinical Valu

Author:Wang, Yan; Sun, Jiawei; Wang, Di; Liu, Hongguang; Ma, Qing; Chen, Shuo

Journal: CANCER INVESTIGATION. 2025; Vol. 43, Issue 5, pp. 337-354. DOI: 10.1080/07357907.2025.2506102

6
Overexpression FARSB Reveals Poor Prognosis in Breast Cancer and is Correlated with Immunit

Author:Hu, Yueming; Liu, Ting; Tian, Li; Cao, Bohai; Xu, Jinheng

Journal: CANCER INVESTIGATION. 2025; Vol. 43, Issue 5, pp. 326-336. DOI: 10.1080/07357907.2025.2512379

7
The Association Between Vulnerability and Taste Changes in Older Cancer Patients Undergoing Chemotherap

Author:Dong, Yajun; Lu, Jiajia; Wang, Danhui; Zhu, Min; Teng, Liping

Journal: CANCER INVESTIGATION. 2025; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2025.2500495

8
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysi

Author:Tian, Huichun; Zhang, Jiaran; Mao, Lili; Li, Caili; Wei, Xiaoting; Gu, Junjie; Zhou, Li; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Guo, Jun; Si, Lu

Journal: CANCER INVESTIGATION. 2025; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2025.2507113

9
Metabolism-Related Programmed Cell Death: Unveiling Prognostic Biomarkers, Immune Checkpoints, and Therapeutic Strategies in Ovarian Cance

Author:Fu, Mengdi; Wu, Hao; Peng, Peng; Wang, Jinhui; Cao, Dongyan

Journal: CANCER INVESTIGATION. 2025; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2025.2481436


在线咨询

Cancer Investigation

国际简称:CANCER INVEST参考译名:癌症调查

年发文量:87 CiteScore:3.7 是否预警:否 Gold OA文章占比:6.70% 研究类文章占比:86.21%

杂志社联系方式:TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Cancer Investigation